Healthcare

Against the backdrop of the day's trading, an announcement from Artrya Limited (ASX:AYA), released on 2 October 2026, was relevant context for investors tracking the company. Artrya disclosed that it had signed a five-year commercial agreement with Huntsville Hospital Health System (HH Health) for …

Echo IQ Limited (ASX:EIQ) released an announcement on 17 September 2026 providing an update on its engagement with the US Food and Drug Administration regarding the EchoSolv HF 510(k) application. The update followed the company's earlier announcement of an 8 September 2026 regarding an …

In the context of 5 October trading, an announcement from Oceania Healthcare Limited (NZX/ASX:OCA), released on 31 July 2026, provides background for investors. The company announced that itsBoard of Directorshad approved a limited on-market share buyback programme of up to 3.5 million shares over …

On 2 October 2026, 4DMedical shares were trading at $4.34, down 0.46%. The company was included in the S&P/ASX 200indexfrom April 2026, and its full-year results were released in August.

On 2 October 2026, Ansell shares were trading at $44.55, up 0.41%. The company's full-year results, released in August, reported sales andEarningsgrowth and an FY27 outlook.

On 2 October 2026, EBOS shares were trading at $15.14, down 1.88%. The group's full-year results, released in August, marked the completion of a four-year distribution centre renewal program.

On 2 October 2026, Fisher & Paykel Healthcare shares were trading at $36.79, down 1.50%. The company's financial year runs to 31 March, and in August it provided first-half guidance for the 2027 financial year and updated its full-year outlook.